DANAHER CORP /DE/ 8-K

What Happened

• Danaher Corporation (DHR) filed an Form 8‑K on January 12, 2026 to report estimated financial performance for the fourth quarter of 2025. The company issued a press release titled “Danaher CEO to Comment on Financial Performance” and furnished presentation slides for the J.P. Morgan Healthcare Conference scheduled for January 13, 2026.
• The 8‑K was signed by Matthew R. McGrew, Executive Vice President and Chief Financial Officer, and includes the press release and conference slides as furnished exhibits (and an interactive XBRL cover file).

Key Details

• Filing date: January 12, 2026 (Form 8‑K Items 2.02 and 9.01).
• Event: Press release disclosing Danaher’s estimated Q4 2025 financial performance.
• Conference: Presentation materials furnished for the J.P. Morgan Healthcare Conference on January 13, 2026.
• Exhibits include the press release and the selected presentation slides (plus interactive XBRL cover page).

Why It Matters

• The 8‑K gives investors an early look at Danaher’s expected quarterly performance and provides management commentary at a major healthcare investor conference—both can influence near‑term stock sentiment.
• Because the filing describes estimated results (not final audited statements), investors should review the furnished press release and presentation slides for specifics and await formal quarterly filings for audited figures.